Our experts agree that there are many simple ways to minimize the chances of breast cancer returning. Adopting a healthy ...

Patient-derived xenografts (PDX) may accurately predict early recurrence and survival outcomes in triple negative breast cancer (TNBC), offering a potential tool for tailoring treatment strategies to ...

The results of a clinical trial published last month targeted breast cancer "sleeper cells," which are cells that break away ...

Patients with advanced triple negative breast cancer ineligible for immunotherapy may overcome their typically poor prognosis ...

The team, led by oncologist Dr. Angela DeMichele, has advanced a method to identify and attack these dormant cells. Called ...

A newly developed antibody which restricts the growth of treatment-resistant breast cancers offers new hope for patients.

Triple Negative Breast Cancer (TNBC) is one of the most aggresive types of breast cancer. It’s the kind of breast cancer that doesn’t have estrogen receptors, progesterone receptors, and human ...

After beating triple-negative breast cancer at age 45, Raymon Bessix faced it again 13 years later. Now, she's urging younger ...

The breakthrough gives new options for patients whose cancers no longer respond to existing therapies. The post New antibody ...

Anixa Biosciences CEO Dr. Amit Kumar told FOX Business that the company is working on a "game-changing vaccine" that could prevent the recurrence of the most aggressive form of breast cancer. It's ...

Node marking techniques and targeted axillary dissection in patients with cN1 disease undergoing neoadjuvant chemotherapy: Analysis of initial 500 participants in the ATNEC trial. This is an ASCO ...